Zentalis Pharmaceuticals Llc (ZNTL) has had the highest return since January 1, 2026 by a US stock with an IPO date in 2020, returning 203%.
| ASSET | % RETURN |
|---|---|
Zentalis Pharmaceuticals Llc (ZNTL) | 202.96% |
Tango Therapeutics (TNGX) | 173.45% |
Enliven Therapeutics (ELVN) | 168.26% |
Rackspace Technology (RXT) | 149.31% |
Obsidian Energy (OBE) | 127.24% |
Biodesix (BDSX) | 121.01% |
Spire Global (SPIR) | 115.16% |
Occidental Petroleum (OXY.WT) | 94.74% |
Allegro Microsystems (ALGM) | 84% |
Revolution Medicines (RVMD) | 83.35% |
Hafnia (HAFN) | 82.78% |
Shattuck Labs (STTK) | 79.18% |
Alx Oncology Holdings (ALXO) | 70.8% |
Nkarta (NKTX) | 64.71% |
Prelude Therapeutics (PRLD) | 61.03% |
Latch (LTCH) | 60% |
California Resources (CRC) | 58.38% |
Atea Pharmaceuticals (AVIR) | 57.3% |
Relay Therapeutics (RLAY) | 55.69% |
Nanobiotix (NBTX) | 53.1% |
C4 Therapeutics (CCCC) | 52.31% |
Skillz Platform (SKLZ) | 52.28% |
Rush Street Interactive (RSI) | 51.45% |
Mediaco (MDIA) | 48.88% |
Sound (SOGP) | 47.54% |